ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer

Oncogene

Volumn 35, Issue 12, 2016, Pages 1493-1503

  Latina, A ^a   Viticchie G ^a   Lena, A M ^a   Piro, M C ^a   Annicchiarico Petruzzelli, M ^b   Melino, G ^a,c   Candi, E ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CYTOGLOBIN; DOXORUBICIN; GLOBIN; HYDROGEN PEROXIDE; NITRIC OXIDE; NP63 PROTEIN; OXYGEN; PROTEIN P63; REACTIVE OXYGEN METABOLITE; RNA DIRECTED DNA POLYMERASE; SCAVENGER; UNCLASSIFIED DRUG; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LUNG CANCER; LUNG CANCER CELL LINE; MCF 7 CELL LINE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; OXYGEN DIFFUSION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CYTOLOGY; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GLOBINS; HUMANS; KERATINOCYTES; LUNG NEOPLASMS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84932087603     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.222     Document Type: Article

References (89)

1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, deathinducing, and dominant-negative activities. Mol Cell 1998; 2: 305-316
2. Candi E, Dinsdale D, Rufini A, Salomoni P, Knight RA, Mueller M, et al. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 2007; 6: 274-285
3. Vanbokhoven H, Melino G, Candi E, Declercq W. p63, a story of mice and men. J Invest Dermatol 2011; 131: 1196-1207
4. Rinne T, Clements SE, Lamme E, Duijf PH, Bolat E, Meijer R, et al. A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes. Hum Mol Genet 2008; 17: 1968-1977
5. Crum CP, McKeon FD. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 2010; 5: 349-371
6. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-718
7. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-713
8. Candi E, Rufini A, Terrinoni A, Dinsdale D, Ranalli M, Paradisi A, et al. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 2006; 13: 1037-4
9. Candi E, Rufini A, Terrinoni A, Giamboi-Miraglia A, Lena AM, Mantovani R, et al. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci USA 2007; 104: 11999-12004
10. Romano RA, Smalley K, Magraw C, Serna VA, Kurita T, Raghavan S, et al. DeltaNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Development 2012; 139: 772-782
11. Rufini A, Weil M, McKeon F, Barlattani A, Melino G, Candi E. p63 protein is essential for the embryonic development of vibrissae and teeth. Biochem Biophys Res Commun 2006; 340: 737-741
12. Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA, Thesleff I. p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development 2006; 133: 1553-1563
13. Shalom-Feuerstein R, Lena AM, Zhou H, De La Forest Divonne S, Van Bokhoven H, Candi E, et al. δNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 2011; 18: 887-896
14. Lena AM, Cipollone R, Amelio I, Catani MV, Ramadan S, Browne G, et al. Skn-1a/Oct-11 and δNp63α exert antagonizing effects on human keratin expression. Biochem Biophys Res Commun 2010; 401: 568-573
15. Candi E, Cipollone R, Rivetti Di Val Cervo P, Gonfloni S, Melino G, Knight R. p63 in epithelial development. Cell Mol Life Sci 2008; 65: 3126-3133
16. Candi E, Terrinoni A, Rufini A, Chikh A, Lena AM, Suzuki Y, et al. p63 is upstream of IKK alpha in epidermal development. J Cell Sci 2006; 119: 4617-4622
17. Senoo M, Pinto F, Crum CP, McKeon F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129: 523-536
18. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 2006; 20: 3185-3197
19. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Della Gatta G, et al. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 2006; 20: 1028-1042
20. Borrelli S, Candi E, Hu B, Dolfini D, Ravo M, Grober OM, et al. The p63 target HBP1 is required for skin differentiation and stratification. Cell Death Differ 2010; 17: 1896-1907
21. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA, et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006; 8: 551-561
22. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, et al. Perp is a p63-regulated gene essential for epithelial integrity. Cell 2005; 120: 843-856
23. Yan W, Chen X. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J Biol Chem 2006; 281: 7856-7862
24. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002; 10: 995-1005
25. Liu G, Chen X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 2002; 21: 7195-7204
26. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med 2000; 28: 463-499
27. Budanov AV. Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling. Antioxid Redox Signal 2011; 15: 6-10
28. Bause AS, Matsui M, Haigis MC. The protein deacetylase SIRT3 prevents oxidative stress-induced keratinocyte differentiation. J Biol Chem 2013; 288: 36484-36491
29. Dhar A, Young MR, Colburn NH. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 2002; 235: 185-193
30. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006; 126: 2565-2575
31. Wajcman H, Kiger L, Marden MC. Structure and function evolution in the superfamily of globins. C R Biol 2009; 332: 273-282
32. Burmester T, Ebner B, Weich B, Hankeln T. Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. Mol Biol Evol 2002; 19: 416-442
33. Schmidt M, Gerlach F, Avivi A, Laufs T, Wystub S, Simpson JC, et al. Cytoglobin is a respiratory protein in connective tissue and neurons, which is up-regulated by hypoxia. J Biol Chem 2004; 279: 8063-8069
34. John R, Chand V, Chakraborty S, Jaiswal N, Nag A. DNA damage induced activation of Cygb stabilizes p53 and mediates G1 arrest. DNA Repair 2014; 24: 107-112
35. Fordel E, Geuens E, Dewilde S, Rottiers P, Carmeliet P, Grooten J, et al. Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR. Biochem Biophys Res Commun 2004; 319: 342-348
36. Yu X, Gao D. Overexpression of cytoglobin gene inhibits hypoxic injury to SHSY5Y neuroblastoma cells. Neural Regen Res 2013; 8: 2198-2203
37. Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D, et al. Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci Lett 2007; 410: 146-151
38. Stagner JI, Parthasarathy SN, Wyler K, Parthasarathy RN. Protection from ischemic cell death by the induction of cytoglobin. Transplant Proc 2005; 37: 3452-3453
39. Shaw RJ, Omar MM, Rokadiya S, Kogera FA, Lowe D, Hall G L, et al. Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. Br J Cancer 2009; 101: 139-144
40. Rivetti Di Val, Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, et al. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci USA 2012; 109: 1133-1138
41. Katsuyama M, Matsuno K, Yabe-Nishimura C. Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme. J Clin Biochem Nutr 2012; 50: 9-22
42. Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003; 63: 7113-7121
43. Ramsey MR, Wilson C, Ory B, Rothenberg SM, Faquin W, Mills AA, et al. FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J Clin Invest 2013; 123: 3525-3538
44. Park ES, Kim SD, Lee MH, Lee HS, Lee IS, Sung JK, et al. Protective effects of N-acetylcysteine and selenium against doxorubicin toxicity in rats. J Vet Sci 2003; 4: 129-136
45. Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F, Roop DR. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 2000; 60: 4016-4020
46. Ogawa E, Okuyama R, Ikawa S, Nagoshi H, Egawa T, Kurihara A, et al. p51/p63 Inhibits ultraviolet B-induced apoptosis via Akt activation. Oncogene 2008; 27: 848-856
47. Kenyon CJ. The genetics of ageing. Nature 2010; 464: 504-512
48. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120: 483-495
49. d'Adda Di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8: 512-522
50. Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 2009; 36: 2-14
51. Rufini A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, et al. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev 2012; 26: 2009-2014
52. Italiano D, Lena AM, Melino G, Candi E. Identification of NCF2/p67phox as a novel p53 target gene. Cell Cycle 2012; 11: 4589-4596
53. Patel A, Burton DG, Halvorsen K, Balkan W, Reiner T, Perez-Stable C, et al. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways. Oncogene 2014; 34: 2586-2596
54. Leikam C, Hufnagel A, Walz S, Kneitz S, Fekete A, Müller MJ, et al. Cystathionase mediates senescence evasion in melanocytes and melanoma cells. Oncogene 2014; 33: 771-782
55. Wolyniec K, Levav-Cohen Y, Jiang YH, Haupt S, Haupt Y. The E6AP E3 ubiquitin ligase regulates the cellular response to oxidative stress. Oncogene 2013; 32: 3510-3519
56. Nakanome A, Brydun A, Matsumoto M, Ota K, Funayama R, Nakayama K, et al. Bach1 is critical for the transformation of mouse embryonic fibroblasts by Ras (V12) and maintains ERK signaling. Oncogene 2013; 32: 3231-3245
57. Agrelo R, Kishimoto H, Novatchkova M, Peraza V, Paolino M, Souabni A, et al. SATB1 collaborates with loss of p16 in cellular transformation. Oncogene 2013; 32: 5492-5500
58. Gao B, Li K, Wei YY, Zhang J, Li J, Zhang L, et al. Zinc finger protein 637 protects cells against oxidative stress-induced premature senescence by mTERT-mediated telomerase activity and telomere maintenance. Cell Death Dis 2014; 5: e1334
59. Li C, Chang DL, Yang Z, Qi J, Liu R, He H, et al. Pin1 modulates p63α protein stability in regulation of cell survival, proliferation and tumor formation. Cell Death Dis 2013; 4: e943
60. Burnley P, Rahman M, Wang H, Zhang Z, Sun X, Zhuge Q, et al. Role of the p63-FoxN1 regulatory axis in thymic epithelial cell homeostasis during aging. Cell Death Dis 2013; 4: e932
61. Wiel C, Augert A, Vincent DF, Gitenay D, Vindrieux D, Le Calvé B, et al. Lysyl oxidase activity regulates oncogenic stress response and tumorigenesis. Cell Death Dis 2013; 4: e855
62. Wansleben S, Davis E, Peres J, Prince S. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Cell Death Dis 2013; 4: e846
63. Paris M, Rouleau M, Pucéat M, Aberdam D. Regulation of skin aging and heart development by TAp63. Cell Death Differ 2012; 19: 186-193
64. Sommer M, Poliak N, Upadhyay S, Ratovitski E, Nelkin BD, Donehower LA, et al. DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle 2006; 5: 2005-2011
65. Keyes WM, Wu Y, Vogel H, Guo X, Lowe SW, Mills AA. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 2005; 19: 1986-1999
66. DeYoung MP, Johannessen CM, Leong CO, Faquin W, Rocco JW, Ellisen LW. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res 2006; 66: 9362-9368
67. Ramsey MR, He L, Forster N, Ory B, Ellisen LW. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. Cancer Res 2011; 1: 4373-4379
68. Genin O, Rechavi G, Nagler A, Ben-Itzhak O, Nazemi KJ, Pines M. Myofibroblastin pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment. Neoplasia 2008; 10: 940-948
69. Xinarianos G, McRonald FE, Risk JM, Bowers NL, Nikolaidis G, Field JK, et al. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer. Hum Mol Genet 2006; 15: 2038-2044
70. Shaw RJ, Omar MM, Rokadiya S, Kogera FA, Lowe D, Hall GL, et al. Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. Br J Cancer 2009; 101: 139-144
71. Oleksiewicz U, Liloglou T, Tasopoulou KM, Daskoulidou N, Bryan J, Gosney JR, et al. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines. Hum Mol Genet 2013; 22: 3207-3217
72. Gorr TA, Wichmann D, Pilarsky C, Theurillat JP, Fabrizius A, Laufs T, et al. Old proteins-new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells. Acta Physiol 2011; 202: 563-581
73. Emara M, Turner AR, Allalunis-Turner J. Hypoxic regulation of cytoglobin and neuroglobin expression in human normal and tumor tissues. Cancer Cell Int 2010; 10: 33-38
74. Presneau N, Dewar K, Forgetta V, Provencher D, Mes-Masson AM, Tonin PN. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2. Mol Carcinog 2005; 43: 141-154
75. McRonald FE, Liloglou T, Xinarianos G, Hill L, Rowbottom L, Langan JE, et al. Downregulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression. Hum Mol Genet 2006; 15: 1271-1277
76. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305
77. Rivera A, Maxwell SA. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 2005; 280: 29346-29354
78. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 2005; 11: 1306-1313
79. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66(Shc). Science 2007; 315: 659-663
80. Drane P, Bravard A, Bouvard E, May E. Reciprocal down-regulation of p53 and sod2 gene expression-implication in p53 mediated apoptosis. Oncogene 2001; 20: 430-439
81. Dhar SK, Xu Y, Chen Y, St. Clair DK. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 2006; 281: 21698-21709
82. Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, et al. Regulation of AIF expression by p53. Cell Death Differ 2006; 13: 2140-2149
83. Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, et al. Tigar, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 107-120
84. Berkers CR, Maddocks OD, Cheung EC, Mor I, Vousden KH. Metabolic regulation by p53 family members. Cell Metab 2013; 18: 617-633
85. Kouwenhoven EN, Van Heeringen SJ, Tena JJ, Oti M, Dutilh BE, Alonso ME, et al. Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet 2010; 6: e1001065
86. Celardo I, Grespi F, Antonov A, Bernassola F, Garabadgiu AV, Melino G, et al. Caspase-1 is a novel target of p63 in tumor suppression. Cell Death Dis 2013; 4: e645
87. Amelio I, Amelio I, Markert EK, Rufini A, Antonov AV, Sayan BS, et al. p73 regulates serine biosynthesis in cancer. Oncogene 2014; 33: 5039-5046
88. Guo XM, Philipsen S, Tan-Un KC. Characterization of human cytoglobin gene promoter region. Biochim Biophys Acta 2006; 1759: 208-215
89. Browne G, Cipollone R, Lena AM, Serra V, Zhou H, Van Bokhoven H, et al. Differential altered stability and transcriptional activity of δNp63. J Cell Sci 2011; 124: 2200-2207